One shot before surgery could ease wisdom tooth recovery
NCT ID NCT07450638
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single injection of dexamethasone, a long-acting steroid, given 30 minutes before wisdom tooth removal can lessen post-surgery pain, facial swelling, and trouble opening the mouth. Sixty adults aged 18 to 35 are randomly assigned to receive either the steroid or a placebo. The goal is to see if this simple step improves recovery and reduces the need for painkillers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Dexamethasone injection
- What this could lead to
- If it works, this could give dentists a simple way to ease recovery after wisdom tooth removal.
- What could go wrong
- This is a small, early-stage trial with only 60 people. Results may not apply to everyone, and steroids have risks like allergic reactions or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-35 years * Indicated for surgical removal of impacted mandibular third molars (Pell \& Gregory Class II-III) * ASA I or II (healthy or mild systemic disease) * Willing to provide informed consent Exclusion Criteria: * Known allergy to corticosteroids * Systemic diseases contraindicating steroid use (e.g., uncontrolled diabetes, immunosuppression) * Pregnancy or lactation * Acute pericoronitis or local infection * Current use of steroids or NSAIDs
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Facial swelling are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Oral & Maxillofacial Surgery, Al Salam University
Tanta, Gharbia Governorate, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common anesthetic stop Post-Surgery delirium in the elderly?
- Can a single drug dose curb opioid side effects after kidney stone surgery?
- Can a new Non-Opioid pill cut painkiller needs after throat surgery?
- Can zapping three acupoints rewire the brain to ease surgical pain?
- Can a triage checklist ease pain months after emergency surgery?
- Nature vs. art: which virtual world calms dental patients best?